BioSpace News Archive

Business

Synteract Appoints Jack Shannon as New Chief Commercial Officer

He joins Synteract from Chiltern, a Covance company, where he was vice president, Global Business Development Biopharma.

January 30, 2018
·
2 min read
Business

Helsinn and the Scientific Centre of Monaco Sign Collaboration Agreement

ccRCC is diagnosed in over 200,000 patients worldwide each year and the number of people affected continues to increase.

January 30, 2018
·
3 min read
Drug Development

Corbus Pharma Announces Agreement With FDA on Phase IIb Cystic Fibrosis Study Design with Pulmonary Exacerbations as Sole Primary Endpoint

The Company and the FDA agreed that the event rate of pulmonary exacerbation is an acceptable sole primary efficacy endpoint for the clinical development program to support registration of lenabasum for the treatment of CF.

January 30, 2018
·
9 min read
Pharm Country

Medicrea Reports Directors’ Dealings Disclosure

MEDICREA, pioneering the convergence of healthcare IT and next-generation, outcome-centered device design and manufacturing with UNiD ASI technology, announces transactions on securities of the Company by its Chairman and Chief Executive Officer.

January 30, 2018
·
1 min read
Biotech Bay

Bay Area’s Halo Neuroscience Scores $13M Series B

The investment was led by TPG with additional funding from existing investors Lux Capital, JAZZ Venture Partners, and Xfund.

January 30, 2018
·
2 min read
Business

Henkel Opens State-of-the-Art Research and Development Facilities in Stamford and Trumbull, Conn.

On Friday, January 26, 2018, Henkel held ribbon cutting ceremonies at two new research and development facilities in Trumbull and Stamford.

January 30, 2018
·
5 min read
Business

Penumbra Schedules Fourth Quarter and Full Year 2017 Earnings Release and Conference Call for February 27, 2018 at 5:00 PM Eastern Time

A press release with fourth quarter and full year 2017 financial results will be issued after market close that day.

January 30, 2018
·
1 min read
Genetown

Syros Announces Proposed Offering of Common Stock

Syros announced that it is offering to sell, subject to market and other conditions, $40.0 million of its common stock in an underwritten public offering.

January 30, 2018
·
5 min read
Business

Vanda Pharma to Announce Fourth Quarter and Full Year 2017 Financial Results on February 14, 2018

Vanda will host a conference call at 4:30 PM ET on Wednesday, February 14, 2018, during which management will discuss the fourth quarter and full year 2017 financial results and other corporate activities.

January 30, 2018
·
1 min read
Business

Medizone International Appoints Jude Dinges to Executive Team

Medizone today announced the appointment of Jude P. Dinges, as its Executive VP - Commercial Operations.

January 30, 2018
·
3 min read